Ordinary profit, ROE and new functional materials sales ratio targets under the 22 Medium-Term Management Plan
First written in FY2022. 2 of 6 entries say "Advanced", first in FY2026. Latest entry: 2026-08-07.
No other company in this theme has enough history to compare yet.
- 2026-08-07AdvancedManagement Planning
「Progress is broadly in line with the plan toward the final year of the 25 Medium-Term Management Plan, FY2027.」
Progress has been updated against the FY2027 targets of the 25 Medium-Term Management Plan, with FY2025 actual results and the FY2026 forecast shown for revenue, ordinary profit and ROE. - FY2026AdvancedAnnual report
「25 Medium-Term Management Plan Progress Fiscal 2027 (final fiscal year) Net sales: ¥10.2 billion Fiscal 2025 results: ¥9.1 billion Fiscal 2026 forecast: ¥9.6 billion Ordinary income: ¥800 million Fiscal 2025 results: ¥580 million Fiscal 2026 forecast: ¥530 million ROE: 4.4% Fiscal 2025 results: 3.2% Fiscal 2026 forecast: 2.6%」
Against the fiscal 2027 targets under the 25 Medium-Term Management Plan, the Company disclosed first-year net sales of ¥9.1 billion, ordinary income of ¥580 million and ROE of 3.2%, as well as its fiscal 2026 forecasts. - FY2025ReframedAnnual report
「The Company targets fiscal 2027, the final fiscal year of the 25 Medium-Term Management Plan, of ¥10.2 billion in net sales, ¥800 million in ordinary income and ROE of 4.4%.」
The Company summarized the targets and results for ordinary income, ROE and the ratio of sales from new functional materials under the 22 Medium-Term Management Plan, then transitioned to the sales, ordinary income and ROE targets under the 25 Medium-Term Management Plan through fiscal 2027. - FY2024Disclosure of fiscal 2023 results and fiscal 2024 forecastsAnnual report
「Ordinary income: fiscal 2022 results ¥740 million; fiscal 2023 results ¥470 million; fiscal 2024 forecast ¥510 million ROE: fiscal 2022 results 4.4%; fiscal 2023 results 2.2%; fiscal 2024 forecast 2.9% Ratio of sales from new functional materials: fiscal 2022 results 0.8%; fiscal 2023 results 1.8%; fiscal 2024 forecast 3.8%」
For the financial KPIs under the 22 Medium-Term Management Plan, the Company disclosed fiscal 2023 results and its fiscal 2024 forecast. Ordinary income, ROE and the ratio of sales from new functional materials are all forecast to fall below the fiscal 2024 targets. - FY2023Disclosed FY2022 results and FY2023 forecastsAnnual report
「Ordinary income: fiscal 2022 results ¥740 million; fiscal 2023 forecast ¥1.00 billion ROE: 4.4%; 5.5% Ratio of sales from new functional materials: 0.8%; 3.6%」
The Company disclosed actual results for fiscal 2022 and forecasts for fiscal 2023 for the 22 Medium-Term Management Plan KPIs, showing progress toward the fiscal 2024 targets. - FY2022First statedAnnual report
「The Medium-Term Management Plan sets targets for fiscal 2024, its final fiscal year, of ordinary income of ¥1.34 billion, ROE of 6.9% and a 7.8% ratio of sales from new functional materials.」
As financial KPIs under the 22 Medium-Term Management Plan, the Company set ordinary income targets of ¥1.00 billion, ¥1.13 billion and ¥1.34 billion for fiscal 2022 through fiscal 2024, respectively; ROE targets of 5.9%, 6.2% and 6.9%; and targets for the ratio of sales from new functional materials of 3.2%, 5.2% and 7.8%.